Endothelial cells of tumor vessels: Abnormal but not absent

Cancer and Metastasis Reviews

Volumn 19, Issue 1-2, 2000, Pages 109-120

  McDonald, Donald M ^a   Foss, Alexander J E ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Angiogenesis; Blood vessels; Electron microscopy; Immunohistochemistry; Microvasculature; Plasma leakage; Vascular permeability

Indexed keywords

ANGIOGENESIS; BLOOD VESSEL PERMEABILITY; CELL MIGRATION; CELL ULTRASTRUCTURE; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; PRIORITY JOURNAL; REVIEW; TUMOR BLOOD FLOW; TUMOR VASCULARIZATION;

ANIMALS; ENDOTHELIUM, VASCULAR; HUMANS; MELANOMA; MICE; MICROCIRCULATION; NEOPLASM CIRCULATING CELLS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; UVEAL NEOPLASMS;

EID: 0034531951     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026529222845     Document Type: Review

References (115)

1. Malignant melanomata of the choroid. Montgomery Memorial Lecture 1961
2. Malignant melanoma of the choroid of a peculiar cavernous type
3. Cysts and tumours of the uveal tract
4. Physico-anatomical studies of spontaneous and experimental intraocular newgrowths: Vascular supply
5. The 'Knapp-Ronne' type of malignant melanoma of the choroid: A haemangioma-like melanoma with a typical clinical picture. So-called 'preretinal malignant choroidal melanoma'
6. The growth of the blood supply to melanoma transplants in the hamster cheek pouch
7. The vascular morphology of tumors
8. Scanning electron microscopy of frozen-cracked, dry-cracked and enzyme-digested tissue of human malignant choroidal melanomas
9. The fine structure of tumor blood vessels. I. Participation of non-endothelial cells in tumor angiogenesis
10. The vasculature of xenotransplanted human melanomas and sarcomas on nude mice. II. Scanning and transmission electron microscopic studies
11. Blood flow influences vascular growth during tumour angiogenesis
12. Abundance of neoplastic cells in vessel walls of human tumor xenografts
13. Determinants of tumor blood flow: A review
14. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review
15. Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry
16. Vasculogenic mimicry and tumor angiogenesis
17. Vasculogenic mimicry: How convincing, how novel, and how significant?
18. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules
19. Microvascular architecture in a mammary carcinoma: Branching patterns and vessel dimensions
20. Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels
21. Microvascular corrosion casting in the study of tumor vascularity: A review
22. Geometric resistance and microvascular network architecture of human colorectal carcinoma
23. Openings between defective endothelial cells explain tumor vessel leakiness
24. Structural and functional characteristics of the microcirculation in neoplasms
25. The vascular architecture of human xenotransplanted tumors: Histological, morphometrical, and ultrastructural studies
26. Microvessel quantification in primary colorectal carcinoma: An immunohistochemical study
27. Laminin and collagen IV subunit distribution in normal and neoplastic tissues of colorectum and breast
28. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: Implications for antiangiogenic tumor therapies
29. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
30. The significance of free blood in liquid and solid tumours
31. Pituitary tumorigenesis in aging female C57BL/6J mice: A light and electron microscopic study
32. The relationship between the capillary structure and hemorrhage in gliomas
33. Estrogen-induced tumors: Changes in the vasculature in two strains of rat
34. Traumatic enucleation for posterior uveal melanoma
35. Angiosarcoma of soft tissue: A study of 80 cases
36. Intracerebral tumor-associated hemorrhage caused by over-expression of the vascular endothelial growth factor isoforms VEGF 121 and VEGF165 but not VEGF189
37. Clinically uninvolved skin in AIDS: Evidence of atypical dermal vessels similar to early lesions observed in Kaposi's sarcoma. Ultrastructural study in four patients
38. Ultrastructural study of Kaposi's sarcoma
39. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice
40. Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS 174T in SCID mice
41. Tumor angiogenesis and interstitial hypertension
42. Fractal characteristics of tumor vascular architecture during tumor growth and regression
43. Evaluation of microvascularization pattern visibility in human choroidal melanomas: Comparison of confocal fluorescein with indocyanine green angiography
44. Transgenic mouse models of tumour angiogenesis: The angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models
45. Expression of platelet-endothelial cell adhesion molecule-1 (PECAM-1) during melanoma-induced angiogenesis in vivo
46. Up-regulation of endoglin on vascular endothelial cells in human solid tumors: Implications for diagnosis and therapy
47. Vascular permeability factor/vascular endothelial growth factor: An important mediator of angiogenesis in malignancy and inflammation
48. Definition of two angiogenic pathways by distinct alpha v integrins
49. Mechanisms of angiogenesis
50. Vascular endothelial growth factor as a marker of tumor endothelium
51. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
52. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer
53. Regulation of anglogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin
54. Antibody-directed targeting of the vasculature of solid tumors
55. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
56. Prostate-specific membrane antigen (PSMA)-specific monoclonal antibodies in the treatment of prostate and other cancers
57. Vascular targeting with phage peptide libraries
58. Imaging of tumour neovasculature by targeting the TGF-beta binding receptor endoglin
59. Endoglin is a suitable target for efficient imaging of solid tumors: In vivo evidence in a canine mammary carcinoma model
60. Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer
61. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens - Evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor
62. CD31 immunoreactivity in mesenchymal neoplasms of the skin and subcutis: Report of 145 cases and review of putative immunohistologic markers of endothelial differentiation
63. An immunocytochernical assessment of 19 cases of cutaneous angiosarcoma
64. Endothelial CD34 is suppressed in human malignancies: Role of angiogenic factors
65. Breast carcinoma: Vascular density determined using CD105 antibody correlates with tumor prognosis
66. Microvessel density as a predictor of PSA recurrence after radical prostatectomy. A comparison of CD34 and CD31
67. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
68. Alpha-V/beta-3 and alpha-V/beta-5 integrin distribution in neoplastic kidney
69. Expression of alpha(v)beta 3 integrin is less frequent inovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas
70. Immunohistochemical analysis of integrin alphavbeta3 expression on tumor-associated vessels of human carcinomas
71. Vascular integrin alpha(v)beta3: A new prognostic indicator in breast cancer
72. Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide
73. Expression of VE (vascular endothelial)-cadherin and other endothelial-specific markers in haemangiomas
74. Alteration of interendothelial adherens junctions following tumor cell-endothelial cell interaction in vitro
75. Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice
76. cDNA cloning and sequencing, gene expression, and immunolocalization of thrombomodulin in the Sprague-Dawley rat
77. Distribution of endothelial and basement membrane markers in angiogenic tumors of the nervous system
78. Comparison of Ulex europaeus I lectin and factor VIII-related antigen in vascular lesions
79. Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumors
80. Expression of thrombomodulin in astrocytomas of various malignancy and in gliotic and normal brains
81. Association with clinical outcome of expression of VLA-4 in primary, cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels
82. Cell adhesion molecule expression by vascular endothelial cells as an immune/inflammatory reaction, in human colon carcinoma
83. Denovo expression of the cell adhesion molecule E-selectin on gastric cancer endothelium
84. Expression of E-selectin on endothelial cells of small veins in human colorectal cancer
85. E-selectin is present in proliferating endothelial cells in human hemangiomas
86. Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells
87. Serum concentration of E-selectin in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma
88. Identification of sialyl Lewis-x in squamous cell carcinoma of the head and neck
89. Identification of PECAM-1 in solid tumor cells and its potential involvement in tumor cell adhesion to endothelium
90. Expression of thrombomodulin in esophageal squamous cell carcinoma and its relationship to lymph node metastasis
91. Immunoreactivity of sinusoids in hepatoblastoma: An immunohistochemical study using lectin UEA-I and antibodies against endothelium-associated antigens, including CD34
92. Thrombomodulin expression in transitional cell carcinoma
93. Expression of PECAM-1/CD31 isoforms in human brain gliomas
94. Expression of thrombomodulin in squamous cell carcinoma of the lung: Its relationship to lymph node metastasis and prognosis of the patients
95. Circulating activated endothelial cells in sickle cell anemia
96. The histogenesis of angiosarcoma of the face and scalp: An immunohistochemical and ultrastructural study
97. Characterization of EN4 monoclonal antibody: A reagent with CD31 specificity
98. Immunohistochemical studies on endothelial cell phenotype in hepatocellular carcinoma
99. Heterogeneity of spindle cells in Kaposi's sarcoma: Comparison of cells in lesions and in culture
100. Endothelial cell marker PAL-E reactivity in brain tumor, developing brain, and brain disease
101. Expression of the 85-kd membrane protein in primary human breast cancer: Relationship to hormone receptor levels, DNA ploidy, and tumor grade
102. Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium
103. Prostate-specific membrane antigen expression in normal and malignant human tissues
104. Prostate-specific membrane antigen is produced in tumor-associated neovasculature
105. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature
106. Human von Willebrand factor gene sequences target expression to a subpopnlation of endothelial cells in transgenic mice
107. Targeting of transgene expression to the vascular endothelium of mice by homologous recombination at the thrombomodulin locus
108. A vascular bed-specific pathway
109. Endothelial gaps and permeability of venules in rat tracheas exposed to inflammatory stimuli
110. The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: A matched case-control study
111. The prognostic value of tumor blood vessel morphology in primary uveal melanoma
112. Metastatic uveal melanoma. A morphologic and immunohistochemical analysis
113. Blood flow influences vascular growth during tumor angiogenesis